Degarelix Superior to Leuprolide, Study Finds - Renal and Urology News
Links shared publicly online about this topic.
- 498total visits
Degarelix Superior to Leuprolide, Study Finds - Renal and Urology News
ORLANDO--"Prostate cancer (PCa) patients treated with degarelix have a lower risk of PSA failure or death compared with those treated with leuprolide, according to the findings of a long-term study.
View full resource at renalandurologynews.com
Tags: Cancer, Prostate Cancer Medication, Kidney Health, Urinary System, Lupron, Leuplin, Urology
Most Recently Shared on February 18, 2011 at 8:44 am By:
Degarelix Superior to Leuprolide, Study Finds: ORLANDO—Prostate cancer (PCa) patients treated with degarelix hav... http://bit.ly/hdzXLh
Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON or Crossed Over to FIRMAGON From Leuprolide - Drugs.com MedNews
drugs.com — “Findings presented at annual urology meeting A poster entitled, Time to Progression in Patients with Prostate Cancer A Comparison of Continuous Degarelix versus” View full resource at drugs.com
Most Recently Shared on May 16, 2011 at 5:05 pm By:
Drugs and Devices OW OW Health
Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Tre... http://bit.ly/lAzBmz #drug
Advertisement
